A p-tau217 blood test predicted a 78% chance of cognitive decline within 10 years for symptom-free adults with very high levels of the biomarker.
First death reported in Upper East Side Legionnaires' disease outbreak as cases rise to 67Doctors warn your 'stomach bug' may actually be a parasite that's harder to detectIs lettuce still safe to eat amid Taco Bell illness probe?
Doctors answer'Miracle on the Hudson' hero Captain 'Sully' Sullenberger reveals Alzheimer's diagnosisNotable figures who died from the same heart condition linked to Lindsey Graham's deathHeart condition tied to Lindsey Graham's death can strike without warning — what to knowMan turns tragic loss of best friend to suicide into urgent outreach to lonely strangersWildfire smoke sends Cleveland air quality levels near hazardous Young girl allegedly hit by illegal immigrant trucker needs more surgery years after crash, father saysCanadian wildfire smoke chokes up Northwest US, triggers widespread air quality alertsNew blood test may predict Alzheimer's risk Dr. Jeremy Koppel, co-director of the Litwin-Zucker Center, discusses a new blood test capable of predicting Alzheimer's risk up to 10 years in advance.
The test identifies elevated levels of a tau protein biomarker, P-tau217, indicating a higher likelihood of cognitive decline. Koppel highlights its potential for early diagnosis and understanding Alzheimer's progression.may help predict future cognitive decline in older adults up to a decade before any noticeable symptoms appear, according to a new study.
The Harvard-led research, presented at the Alzheimer's Association International Conference in London and simultaneously published in The Journal of the American Medical Association, could transform how doctors assess dementia risk and help patients prepare for the disease. By measuring a blood biomarker called p-tau217, which tracks the build-up of damaging proteins in the brain, clinicians may soon be able to assess Alzheimer's risk much like they useALZHEIMER'S BLOOD TESTS MAY PREDICT SYMPTOMS YEARS IN ADVANCE, BUT EXPERTS URGE CAUTIONA simple blood test measuring the p-tau217 protein could predict future cognitive decline in symptom-free older adults up to 10 years before any noticeable memory problems begin.
They found that symptom-free individuals with very high levels of p-tau217 had an estimated 78% chance of developing cognitive impairment within 10 years, and a roughly one in three chance within five years. Even those with moderately elevated levels faced a 45% risk over a decade. The p-tau217 protein is a modified form of tau, which forms tangles in the brain and is associated with memory loss.
The blood test provided information beyond what standardRachel Buckley, the study’s lead author and an associate professor of neurology at Harvard Medical School, said the findings provide some of the clearest evidence yet that dementia risk can be detected Even individuals with only moderately elevated levels of the biomarker face a significant 45% risk of cognitive decline over 10 years.
"In the future, when treatments are approved for use early in the disease process, these tests could help guide monitoring, treatment decisions and counseling for patients and families," Buckley added. CLICK HERE TO DOWNLOAD THE FOX NEWS APP Maria Carrillo, chief science officer at the Alzheimer’s Association in Chicago, said that targeting the silent stage of the disease before memory issues arise is where "Identifying people at risk earlier could fundamentally change how we diagnose, treat and potentially prevent dementia," she told Fox News Digital, noting that earlier detection could allow people to begin interventions before symptoms develop.writer with Fox News Digital.
She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
Please follow us on Google to support usMedical Research Alzheimers Geriatric Health Brain Health Lifestyle
United States Latest News, United States Headlines
Similar News: You can also read news stories similar to this one that we have collected from other news sources.
David Lynch Dies: ‘Twin Peaks’, ‘Blue Velvet’, ‘Elephant Man’ & ‘Eraserhead’ Visionary Was 78David Lynch, the four-time Oscar-nominee behind ‘Blue Velvet,’ ‘Mulholland Drive’ and ‘The Elephant Man’ who also created TV's ‘Twin Peaks,’ has died at 78.
Read more »
Clara Ester, activist who rushed to Martin Luther King Jr. after he was shot, dies at 78Clara Ester, activist present at Martin Luther King Jr.’s death, dies at age 78.
Read more »
Richard Gere, 78, Faces Backlash Onscreen Age-Gap Romance With Actress, 28The actor is married in real life to a woman 33 years his junior.
Read more »
Bleach Creator Reveals New Soul Reapers for New Story Set After Thousand-Year Blood WarBleach's creator is adding some new Soul Reapers to the roster for a new story set after Thousand-Year Blood War
Read more »